Allogene Therapeutics, Inc. (NASDAQ:ALLO) Shares Sold by Vanguard Group Inc.

Vanguard Group Inc. reduced its position in shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Free Report) by 3.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 8,000,692 shares of the company’s stock after selling 327,007 shares during the period. Vanguard Group Inc.’s holdings in Allogene Therapeutics were worth $17,041,000 at the end […]